Cargando…

Negligible risk of hepatocellular carcinoma in chronic hepatitis B patients in immune-tolerant phase: Myth or fact

Detalles Bibliográficos
Autores principales:	Yip, Terry Cheuk-Fung, Wong, Grace Lai-Hung, Wong, Vincent Wai-Sun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Association for the Study of the Liver 2021
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8046624/ https://www.ncbi.nlm.nih.gov/pubmed/33517606 http://dx.doi.org/10.3350/cmh.2021.0019

Ejemplares similares

Secondary prevention for hepatocellular carcinoma in patients with chronic hepatitis B: are all the nucleos(t)ide analogues the same?
por: Yip, Terry Cheuk-Fung, et al.
Publicado: (2020)

Moving toward hepatitis B virus functional cure - the impact of on-treatment kinetics of serum viral markers
por: Liang, Lilian Yan, et al.
Publicado: (2023)

Alanine Aminotransferase Level: The Road to Normal in 2021
por: Yip, Terry Cheuk‐Fung, et al.
Publicado: (2021)

Aspirin Reduces the Incidence of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B Receiving Oral Nucleos(t)ide Analog
por: Hui, Vicki Wing-Ki, et al.
Publicado: (2021)

Management of hepatitis B virus reactivation due to treatment of COVID-19
por: Yip, Terry Cheuk-Fung, et al.
Publicado: (2022)

Serum fibrosis index-based risk score predicts hepatocellular carcinoma in untreated patients with chronic hepatitis B
por: Liang, Lilian Yan, et al.
Publicado: (2021)

Negligible risks of hepatocellular carcinoma during biomarker-defined immune-tolerant phase for patients with chronic hepatitis B
por: Jeon, Mi Young, et al.
Publicado: (2021)

Two different types of COVID-19 vaccines and serial liver biochemistries
por: Wong, Grace Lai-Hung, et al.
Publicado: (2022)

Three COVID-19 medications-remdesivir, molnupiravir and ritonavir-boosted nirmatrelvir-and serial liver biochemistries in 22, 456 subjects
por: Wong, Grace Lai-Hung, et al.
Publicado: (2022)

Heroin. The myths and the facts
Publicado: (1977)

Tonsuring: Myths and facts
por: Karthikeyan, Kaliaperumal
Publicado: (2009)

Incidence of Viral Rebound After Treatment With Nirmatrelvir-Ritonavir and Molnupiravir
por: Wong, Grace Lai-Hung, et al.
Publicado: (2022)

Non-invasive biomarkers for liver inflammation in non-alcoholic fatty liver disease: present and future
por: Yip, Terry Cheuk-Fung, et al.
Publicado: (2023)

Novel machine learning models outperform risk scores in predicting hepatocellular carcinoma in patients with chronic viral hepatitis
por: Wong, Grace Lai-Hung, et al.
Publicado: (2022)

Reply
por: Wong, Grace Lai-Hung, et al.
Publicado: (2023)

U-shaped relationship between urea level and hepatic decompensation in chronic liver diseases
por: Lin, Huapeng, et al.
Publicado: (2022)

Minimal Risk of Drug-Induced Liver Injury With Molnupiravir and Ritonavir-Boosted Nirmatrelvir
por: Wong, Grace Lai-Hung, et al.
Publicado: (2023)

Facts and myths pertaining to fibromyalgia
por: Häuser, Winfried, et al.
Publicado: (2018)

Endometriosis on the Internet – Myths or Facts?
por: Dinh, T., et al.
Publicado: (2020)

Coronaviruses: Facts, Myths, and Hypotheses
por: Carbone, Michele, et al.
Publicado: (2020)

Baveno VII Criteria Is an Accurate Risk Stratification Tool to Predict High-Risk Varices Requiring Intervention and Hepatic Events in Patients with Advanced Hepatocellular Carcinoma
por: Wu, Claudia Wing-Kwan, et al.
Publicado: (2023)

Anatomy of gold catalysts: facts and myths
por: Ranieri, Beatrice, et al.
Publicado: (2015)

Gabapentin-related suicide: Myth or fact?
por: Ghaly, Ramsis F., et al.
Publicado: (2018)

Airborne transmission and precautions: facts and myths
por: Seto, W.H.
Publicado: (2015)

Pattern and impact of hepatic adverse events encountered during immune checkpoint inhibitors – A territory‐wide cohort study
por: Chan, Stephen Lam, et al.
Publicado: (2020)

Baveno VII criteria for recompensation predict transplant-free survival in patients with hepatitis B-related decompensated cirrhosis
por: Hui, Vicki Wing-Ki, et al.
Publicado: (2023)

Association of metformin use on metabolic acidosis in diabetic patients with chronic hepatitis B‐related cirrhosis and renal impairment
por: Yip, Terry Cheuk‐Fung, et al.
Publicado: (2021)

Rewarming: facts and myths from the neurological perspectives
por: Schmutzhard, Erich, et al.
Publicado: (2012)

Rewarming: facts and myths from the systemic perspective
por: Scaravilli, V, et al.
Publicado: (2012)

Oxygen-induced hypercapnia in COPD: myths and facts
por: Abdo, Wilson F, et al.
Publicado: (2012)

The numbers of Libyan doctors in diaspora: Myths and facts
Publicado: (2012)

Facts and myths in serological screening of ART couples
por: Mocanu, E.V.
Publicado: (2012)

Perinatal programming - myths, fact, and future of research
por: Dötsch, Jörg
Publicado: (2014)

Myths and Facts about Vitiligo: An Epidemiological Study
por: Abraham, Suja, et al.
Publicado: (2015)

Hypercalciuria following ceftriaxone a fact or myth
por: Azarfar, Anoush, et al.
Publicado: (2015)

Myths, facts and controversies in the diagnosis and management of anaphylaxis
por: Anagnostou, Katherine, et al.
Publicado: (2019)

Disorders of nutritional status in sepsis – facts and myths
por: Kosałka, Katarzyna, et al.
Publicado: (2017)

Smoking in Renal Transplantation; Facts Beyond Myth
por: Aref, Ahmed, et al.
Publicado: (2017)

Comeback of ketamine: resurfacing facts and dispelling myths
por: Kumar, Abhijit, et al.
Publicado: (2021)

HPV-Associated Breast Cancer: Myth or Fact?
por: Kudela, Erik, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2l7eklcuqja49eisscbgkjl870